| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 170 |
| 1 | INFLIXIMAB | 165 |
| 2 | METHOTREXATE SODIUM | 150 |
| 3 | METHOTREXATE | 135 |
| 4 | ASPIRIN | 117 |
| 5 | ETANERCEPT | 117 |
| 6 | ASPIRIN 325 MG | 114 |
| 7 | ASPIRIN 81 MG | 114 |
| 8 | FRUQUINTINIB | 106 |
| 9 | REGORAFENIB | 98 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 299 |
| 1 | Corticosteroid [EPC] | 224 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 211 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 183 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 135 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 117 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 110 |
| 7 | Proton Pump Inhibitor [EPC] | 106 |
| 8 | Platinum-based Drug [EPC] | 97 |
| 9 | Loop Diuretic [EPC] | 82 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 1 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 9 | 0.0018 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 4 | 0.0018 |
| 4 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 63 | 0.0013 |
| 6 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 8 | Calcitonin [EPC] | 3 | 0.0010 |
| 9 | Blood Viscosity Reducer [EPC] | 4 | 0.0009 |